🥇 First rule of investing? Know when to save! Up to 55% off InvestingPro before BLACK FRIDAYCLAIM SALE

Moderna Inc (MRNA)

NASDAQ
Currency in USD
50.28
-1.53(-2.95%)
Closed
Pre Market
50.60+0.32(+0.64%)
MRNA Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Unusual trading volume
Fair Value
Day's Range
49.9456.70
52 wk Range
49.71170.47
Prev. Close
50.28
Open
56.6
Day's Range
49.94-56.7
52 wk Range
49.71-170.47
Volume
17,842,856
Average Vol. (3m)
4,865,650
1-Year Change
-29.52%
Book Value / Share
Unlock
Fair Value
Unlock
Fair Value Upside
Unlock
MRNA Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
91.10
Upside
+81.19%
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in oversold territory
Show more

Moderna Inc Company Profile

Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune, and cardiovascular diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, influenza, and respiratory syncytial virus, spikevax, and hMPV/PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; public health vaccines consists of Zika, Nipah, Mpox vaccines; and infectious diseases vaccines, such as lyme and norovirus vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; rare disease intracellular therapeutics; and inhaled pulmonary therapeutics. It has strategic alliances and collaborations with AstraZeneca; Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Chiesi Farmaceutici S.p.A.; Metagenomi, Inc.; Carisma Therapeutics, Inc.; CytomX Therapeutics; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; The Bill & Melinda Gates Foundation; and OpenAI. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.

InvestingPro Research for Moderna Inc


Financial Outlook
Analysts project negative EPS for Moderna in the near term, with price targets ranging from $75 to $214, reflecting varied perspectives on the company's future.
Pipeline Potential
Delve into Moderna's diverse pipeline, including promising cancer vaccines and combination flu shots, as the company seeks to offset declining COVID-19 revenue.
RSV Market Entry
Explore Moderna's foray into the competitive RSV vaccine market with mRESVIA, facing established rivals and navigating restrictive vaccination recommendations.
mRNA Transition
Moderna navigates post-pandemic landscape, leveraging its mRNA platform to diversify beyond COVID-19 vaccines amid stock volatility and market challenges.
Read full SWOT analysis

Compare MRNA to Peers and Sector

Metrics to compare
MRNA
Peers
Sector
Relationship
P/E Ratio
−3.3x−8.7x−0.6x
PEG Ratio
0.01−0.060.00
Price / Book
1.7x1.4x2.6x
Price / LTM Sales
3.8x7.0x3.3x
Upside (Analyst Target)
49.2%50.7%45.3%
Fair Value Upside
Unlock12.0%6.1%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS -5.81
Dividend Yield
-
Annualized Payout
-
5-Years Growth
-
Growth Streak

People Also Watch

113.41
MU
+1.41%
517.88
MA
-0.62%
25.48
SMCI
+12.25%
172.91
QCOM
-0.05%
75.92
NKE
+0.80%

FAQ

What Is the Moderna (MRNA) Stock Price Today?

The Moderna stock price today is 50.28

What Stock Exchange Does Moderna Trade On?

Moderna is listed and trades on the NASDAQ stock exchange.

What Is the Stock Symbol for Moderna?

The stock symbol for Moderna is "MRNA."

What Is the Moderna Market Cap?

As of today, Moderna market cap is 19.33B.

What is Moderna Earnings Per Share?

The Moderna EPS is -5.81.

What Is the Next Moderna Earnings Date?

Moderna will release its next earnings report on Feb 20, 2025.

From a Technical Analysis Perspective, Is MRNA a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.